Investigational Drug Information for Molidustat
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the development status for investigational drug Molidustat?
Molidustat is an investigational drug.
There have been 10 clinical trials for Molidustat.
The most recent clinical trial was a Phase 3 trial, which was initiated on February 22nd 2018.
The most common disease conditions in clinical trials are Renal Insufficiency, Chronic, Renal Insufficiency, and Anemia. The leading clinical trial sponsors are Bayer and [disabled in preview].
There are eighteen US patents protecting this investigational drug and three hundred and five international patents.
Summary for Molidustat
| US Patents | 18 |
| International Patents | 305 |
| US Patent Applications | 65 |
| WIPO Patent Applications | 58 |
| Japanese Patent Applications | 14 |
| Clinical Trial Progress | Phase 3 (2018-02-22) |
| Vendors | 49 |
Recent Clinical Trials for Molidustat
| Title | Sponsor | Phase |
|---|---|---|
| Maintenance Treatment of Renal Anemia in Dialysis Subjects | Bayer | Phase 3 |
| A Study of Molidustat for Treatment of Renal Anemia in Peritoneal Dialysis Subjects | Bayer | Phase 3 |
| A Study of Molidustat for Correction of Renal Anemia in Dialysis Subjects | Bayer | Phase 3 |
Clinical Trial Summary for Molidustat
Top disease conditions for Molidustat
Top clinical trial sponsors for Molidustat
US Patents for Molidustat
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Molidustat | See Plans and Pricing | Controlled release dosage form | TRIASTEK, INC. (Nanjing, CN) | See Plans and Pricing |
| Molidustat | See Plans and Pricing | Oral drug dosage forms having desired drug release profiles and uses thereof | Triastek, Inc. (Nanjing, CN) | See Plans and Pricing |
| Molidustat | See Plans and Pricing | Method for the preparation of triazole compounds | BAYER PHARMA AKTIENGESELLSCHAFT (Berlin, DE) | See Plans and Pricing |
| Molidustat | See Plans and Pricing | Compartmented pharmaceutical dosage forms | Triastek, Inc. (Nanjing, CN) | See Plans and Pricing |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Molidustat
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Molidustat | Australia | AU2017261372 | 2036-05-05 | See Plans and Pricing |
| Molidustat | Canada | CA3023278 | 2036-05-05 | See Plans and Pricing |
| Molidustat | China | CN107847398 | 2036-05-05 | See Plans and Pricing |
| Molidustat | European Patent Office | EP3452003 | 2036-05-05 | See Plans and Pricing |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
